Fukuyama Kouji, Okada Motohiro
Department of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan.
Pharmaceuticals (Basel). 2021 Oct 31;14(11):1116. doi: 10.3390/ph14111116.
Accumulating neuropsychopharmacological evidence has suggested that functional abnormalities of astroglial transmission and protein kinase B (Akt) contribute to the pathophysiology and/or pathomechanisms of several neuropsychiatric disorders, such as epilepsy, schizophrenia, affective disorders and antipsychotic-induced convulsions. Therefore, to explore the pathophysiology of mood-stabilising antipsychotics and the proconvulsive actions of atypical antipsychotics, the present study determined the effects of a mood-stabilising, atypical, antipsychotic agent, zotepine (ZTP), on astroglial L-glutamate release and the expression of connexin43 (Cx43) protein in cortical, primary, cultured astrocytes using ultra-high-pressure liquid chromatography and capillary immunoblotting systems. Both acute and subchronic administrations of therapeutically relevant concentrations of ZTP did not affect astroglial L-glutamate release or Cx43 expression in plasma membranes; however, chronic administration of a therapeutically relevant concentration of ZTP increased astroglial L-glutamate release and Cx43 expression in the plasma membrane. Subchronic administrations of a supratherapeutic concentration of ZTP enhanced astroglial L-glutamate release and Cx43 expression in the plasma membrane, whereas acute administration of a supratherapeutic concentration of ZTP enhanced astroglial L-glutamate release without affecting Cx43 expression. These stimulatory effects of ZTP on astroglial L-glutamate release through activated hemichannels and Cx43 trafficking to the astroglial plasma membrane were suppressed by the Akt inhibitor. These results suggest that ZTP enhances astroglial L-glutamate release in a concentration-dependent and time-dependent manner due to the enhanced function of astroglial hemichannels, probably via activation of Akt signalling. Therefore, the enhanced astroglial L-glutamatergic transmission induced by ZTP is, at least partially, involved in the mood-stabilising antipsychotic and proconvulsive actions of ZTP.
越来越多的神经精神药理学证据表明,星形胶质细胞传递功能异常和蛋白激酶B(Akt)参与了多种神经精神疾病的病理生理学和/或发病机制,如癫痫、精神分裂症、情感障碍和抗精神病药物诱发的惊厥。因此,为了探究心境稳定剂类抗精神病药物的病理生理学以及非典型抗精神病药物的促惊厥作用,本研究使用超高压液相色谱法和毛细管免疫印迹系统,测定了一种心境稳定剂类非典型抗精神病药物佐替平(ZTP)对皮质原代培养星形胶质细胞中L-谷氨酸释放及连接蛋白43(Cx43)蛋白表达的影响。治疗相关浓度的ZTP急性和亚慢性给药均不影响星形胶质细胞L-谷氨酸释放或质膜中Cx43的表达;然而,治疗相关浓度的ZTP慢性给药会增加星形胶质细胞L-谷氨酸释放及质膜中Cx43的表达。超治疗浓度的ZTP亚慢性给药可增强星形胶质细胞L-谷氨酸释放及质膜中Cx43的表达,而超治疗浓度的ZTP急性给药可增强星形胶质细胞L-谷氨酸释放,但不影响Cx43的表达。Akt抑制剂可抑制ZTP通过激活半通道对星形胶质细胞L-谷氨酸释放以及Cx43转运至星形胶质细胞质膜的刺激作用。这些结果表明,ZTP可能通过激活Akt信号通路增强星形胶质细胞半通道功能,从而以浓度和时间依赖性方式增强星形胶质细胞L-谷氨酸释放。因此,ZTP诱导的星形胶质细胞L-谷氨酸能传递增强至少部分参与了ZTP的心境稳定抗精神病作用和促惊厥作用。